Medica Share Price (MGP)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Medica Group Plc	LSE:MGP	London	Ordinary Share	GB00BYV24996	ORD 0.2P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	0.00	0.0%	133.00	0.00	01:00:00

Bid Price		Offer Price	High Price	Low Price	Open Price
132.00		137.00	0.00	0.00	0.00

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Health Care Equipment & Services	38.97	9.16	6.62	20.1	148

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
-	O	0	0.00	GBX

Related Shares
Smith & Nephew (SN.), Nmc Health (NMC), Physiomics (PYC), Salvarx (SALV)

Medica (MGP) Latest News

Medica News

Date	Time	Source	Headline
09/10/2019	12:02	UKREG	Medica Group PLC Price Monitoring Extension
01/10/2019	16:41	UKREG	Medica Group PLC Second Price Monitoring Extn
01/10/2019	16:35	UKREG	Medica Group PLC Price Monitoring Extension
30/9/2019	16:41	UKREG	Medica Group PLC Second Price Monitoring Extn
30/9/2019	16:35	UKREG	Medica Group PLC Price Monitoring Extension
17/9/2019	08:24	UKREG	Medica Group PLC Director/PDMR Shareholding
09/9/2019	11:27	ALNC	Medica Raises Dividend On Strong Interim Revenue Growth
09/9/2019	07:18	ALNCF	Alliance News Flash Headline
09/9/2019	07:00	UKREG	Medica Group PLC Interim results demonstrate strong performance
02/9/2019	07:00	UKREG	Medica Group PLC Directorate Change

More Medica News

Medica Takeover Rumours

Medica (MGP) Share Charts

1 Year Medica Chart

1 Month Medica Chart

Intraday Medica Chart

Medica (MGP) Discussions and Chat

Medica Forums and Chat

Date	Time	Title	Posts
10/9/2019	12:25	Medica Group	514
04/8/2009	13:33	Mercury Group: Charts and Comment	254
24/7/2008	15:11	Mercury Group...A New Beginning.	668
14/10/2005	17:59	Mercury Group (Old Cater Barnard) A New Beginning	254
16/4/2004	07:53	Make My Day	5

Add a New Thread

Medica (MGP) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
2019-10-15 15:35:03	133.00	229	304.57	UT
2019-10-15 15:29:51	132.00	414	546.48	AT
2019-10-15 15:14:06	137.00	98	134.26	AT
2019-10-15 14:35:13	133.50	1,264	1,687.44	AT
2019-10-15 14:34:57	133.50	219	292.37	AT

View all Medica trades in real-time

Medica (MGP) Top Chat Posts

Date	Subject
15/10/2019 09:20	Medica Daily Update: Medica Group Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker MGP. The last closing price for Medica was 133p. Medica Group Plc has a 4 week average price of 120.50p and a 12 week average price of 114.50p. The 1 year high share price is 163p while the 1 year low share price is currently 107p. There are currently 111,111,114 shares in issue and the average daily traded volume is 116,960 shares. The market capitalisation of Medica Group Plc is £147,777,781.62. Read Full Thread Reply
13/8/2019 21:32	farview1: I fully agree, but they are clearly not doing that either are they given the share price collapse. Read Full Thread Follow Reply
23/7/2018 21:07	andygibb101: If he got elected then the share price of MGP would be the least of your worries. Read Full Thread Follow Reply
14/6/2018 17:36	ayesha4: Your source is a radiologist? Nighthawk per radiologist is the same. What your contact will not know is that the number of radiologists per shift has gone up dramatically. Three clients waiting in the wings also pending further recruitment. Dayhawk also the same. The share price is going down - the business is doing very well indeed. Get your contact to speak with one of the management to see how the business is doing and feed back to you. He will repeat what I have said. Read Full Thread Follow Reply
10/5/2018 15:23	aishah: This investment trust has a really clever way of picking stocks Strategic Equity Capital taps into a network of experts as well as carrying out specific financial analysis Medica (MGP) grew very strongly at 18% organically last year but the market was expecting 22%, which led to a fall in its share price. There was a slowdown in the fourth quarter due to NHS capacity issues during the winter crisis. However, the fund manager notes the long term structural drivers are strong and Medica is the market leader. He adds that it continues to offer double digit earnings growth and is trading on a PEG ratio of less than 1-times which implies it is cheap. ‘Its cash flow yield is very strong and it has no debt. Our position was reduced last year as it re-rated but this year we’ve been buying back on weakness.’ httPs://www.sharesmagazine.co.uk/article/this-investment-trust-has-a-really-clever-way-of-picking-stocks Read Full Thread Follow Reply
17/1/2018 23:29	thebigshortfella: Hey Velod, Re: "coincidence or what?" I don't think so. I got burnt on VLS on Monday due to the deeply discounted share placing. From 27p to 10p! Now...I noticed on Friday that 10% of IG Index clients with VLS trades had shorts on VLS. This is highly unusual from what I have seen. Obviously I can't prove it but I am convinced that some traders new about the discounted share price... With regards to Medica, I just checked and 8% of IG Index's clients with trades on MGP have shorts. Not good... Re: could only come from a disgruntled ex employee. I recall it. It did make me wonder at the time if the business had some significant operational issues. I have even researched some of the staff on LinkedIn and they don't look hugely impressive. I placed a trade at 227 and it cost me £30k...Ouch... Re: very, very, worrying. It could well be. I am starting to think that the MGP story is just that...I am glad that my trade ended on 19th December. I would have lost a lot more money if I had been in it... BTW I sent you a private message. Thanks! Read Full Thread Follow Reply
22/10/2017 21:37	dibbs: Good post Velod. I think you have pretty much hit the nail on the head! I bought MGP thinking it would be a nice long term hold but with the hope that the share price would have appreciated a little more than it has by now! I bought around May when the chart looked pretty good and I thought there was some momentum evident but that soon fizzled out after my purchases! With hindsight I was a little hasty in taking a position as the PE is pretty rich. I have decided that MGP has loads of positives and with the advancement of time, coupled with IMHO a greater risk of an upside earnings surprise than downside that I would stay put. Hopefully future events here will make me a happier shareholder and persuade you that MGP is on the move! Cheers Dibbs Read Full Thread Follow Reply
20/10/2017 22:08	velod: This post in response to The BigShortFella’s request to me on another forum and is in reply to BSFella. Have no position in this share, nor intention to take one, but now it’s been brought to my attention might put it on a watchlist somewhere, out of sheer Nosey-Parker-interest on my part. Hi BSFella, Had the impression you were a micro-cap guy so surprised this is a quarter billion-pound MCap company. As a trend follower, no I would not buy this, at this juncture, based solely on the share price action alone. Momentum is iffy; albeit with a recent bull trend initiated, but it’s yet to be established if THIS TIME it will hold and build. Can’t understand why as the company as distinct from the share price appears to be a right little belter. Have access to the Piotroski F-Score and (if anyone hasn’t heard of that just Google) was gobsmacked at how MGP, the business, scored. It only goes and achieves top marks! Not only top marks but flying colours too, kind of top Marks! The highest a company can achieve is 9 - and MGP is rated a right royal gold standard 9. You can’t get higher. And that tells me this is one well-run, mean machine business. That being the case, what the hell’s happened to the share price momentum? I’m not built for fundamentals, but things like Return On Capital and ROE are excellent – no wonder it scored so highly on the F-Score. The business per se, independent of the share price rating, is a stonking belter! So why am I not interested? The share price soared until mid-summer. What happened at the height of summer? Because since then the share price has been unimpressive. Why has the market withdrawn its admiration by turning its back on the SP? And why that big retrace today, Friday? Perhaps I should read the posts below; somebody must have an idea. Why has the market withdrawn its initial embrace? Is it the PE ratio? Does the market think the current PE ratio is unworthy and is holding back? It is above the market average but not that much, (Edit, Upon reflection, well - yes that much. It is a 'fair bit' above the average). Unless I trawled through analysts reports something about this share price level, irks the market. Trendlines: It is currently on a little bull rally, but it’s been on and off all summer like that and looks disappointing to me. I, personally don’t trust the share price so wouldn’t take a long position. nor a short position because the share price has no real momentum for either strategy to be reliable. Until a clear trend breaks AND holds it’s a sit it out on the side-lines job for me with this one. Great company. Rubbish share price momentum. Read Full Thread Follow Reply
18/9/2017 23:19	glasshalfull: The share price was down today because MGP failed to deliver sales in line with Investec's forecasts. Investec believe however that full year forecasts can be achieved. "H1 sales were weaker than we expected due to capacity constraints and the timing of contract renewals. Revenues rose 17%, with 6.5% growth in body parts reported. However x-ray sales fell 8% as resources were directed towards the higher value services. The company recruited a net 19 radiologists in the period, with a further 24 added post period-end, consequently we are confident FY estimates can be achieved." --- Hope this assists. I don't hold. Kind regards GHF Read Full Thread Follow Reply
07/9/2017 16:10	lomax99: Shares magazine Medica is a premium growth story The NHS does not have enough radiologists to interpret potentially life-saving scans Teleradiology firm Medica (MGP) is expected to enjoy rapid growth thanks to a surge in demand and a lack of radiologists in the UK. Medica helps to provide early diagnosis of various diseases through its consultant radiologists who interpret computerised tomography (CT) and magnetic resonance imaging (MRI) scans. If these scans identify diseases earlier, it can improve treatment options and outcomes. Strong performance since IPO Berenberg says earnings before interest, tax, depreciation and amortisation and earnings per share are expected to grow at a compound annual growth rate of 16% and 20% respectively between 2017 and 2020. Medica has enjoyed a strong share price performance since its IPO on 21 March 2017 when it raised £121m to pay down borrowings. Since 22 March, the stock has rallied 16.9% to 219.2p. The company currently trades on a forecast 29.8 times earnings per share in the year to 31 December 2018, but Berenberg analyst Charles Weston thinks this premium valuation is ‘justifiedR17; in light of rapid growth. The analyst projects 8% growth per annum in the volume of CT and MRI scans handled by the company, which will be supported by a deficit of radiologists in the UK. There are 4.7 radiologists per 100,000 of the UK general population. This is materially below the Royal College of Radiologists’ target of 8 per 100,000, and is pushing up waiting lists. Outsourcing trends and pricing power One of the ways to tackle this issue is by outsourcing services. Weston says approximately 7% of CT/MRI scans are outsourced. Medica has a dominant position in the UK teleradiology market (50%) and this allows it to charge 5% to 10% more than its rivals. The analyst also highlights that 80% of all clinical decisions are underpinned by imaging and new clinical guidelines for quicker diagnosis of diseases such as cancer and dementia call for scans. Medica provides services to over 100 NHS trusts, as well as private hospitals and diagnostics imaging firms, and intends to expand its services to tackles conditions such as strokes. There are risks associated with the business. Medica needs to ensure it continues to recruit radiologists to meet demand as otherwise growth could be constrained. We were initially cautious on Medica’s dependence on the NHS and Weston also highlights the NHS exposure as a reason for some caution as 99% of sales are derived from NHS Trusts. Despite this nagging concern we are convinced high demand and low supply will drive Medica forward. Read Full Thread Follow Reply
22/8/2017 21:56	thebigshortfella: Dan_the_Epic - I like the fact that you are challenging MGP. Am I right in assuming that you wouldn't trade MGP at its current share price? Read Full Thread Follow Reply

Medica share price data is direct from the London Stock Exchange

Your Recent History

LSE

MGP

Medica

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P: V: D:20191016 06:53:04